RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tanmoy Mondal to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Tanmoy Mondal has written about Radiopharmaceuticals.
Tanmoy Mondal
Connection Strength
0.878
Radiopharmaceuticals
  1. Mondal T, Nautiyal A, Agrawal M, Mitra D, Goel A, Kumar Dey S. 18F-FDG-induced DNA damage, chromosomal aberrations, and toxicity in V79 lung fibroblast cells. Mutat Res Genet Toxicol Environ Mutagen. 2019 Nov; 847:503105.
    View in: PubMed
    Score: 0.681
  2. Nautiyal A, Mondal T, Mitra D, Goel A, Dey SK, Kaushik A. A SIMPLE AND NOVEL APPROACH TO STUDY KINETICS AND ESTIMATE RADIATION DOSES FROM INTERNALLY ADMINISTERED RADIOPHARMACEUTICALS USING AN EXTERNAL DOSE MEASUREMENT SYSTEM. Radiat Prot Dosimetry. 2021 Nov 12; 196(3-4):141-152.
    View in: PubMed
    Score: 0.197
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support